Indications
Supemtek is indicated for active immunisation for the prevention of influenza disease in adults and children from 9 years of age and older. Supemtek should be used in accordance with official recommendations.
Composition
- Active substance
- A/California/07/2009 (H1N1)pdm09-like strain (A/California/07/2009), A/Texas/50/2012 (H3N2)-like strain (A/Texas/50/2012), B/Brisbane/60/2008-like strain (B/Brisbane/60/2008)
- International name (INN)
- trivalent influenza vaccine (recombinant, prepared in cell culture)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Supemtek
- ATC code
- J07BB02
- Therapeutic area
- Influenza, Human